Transparency Market Research
Animal Drug Compounding Market is Predicted to Reach USD 2.4 billion by 2031, Registering a 7.4% CAGR: TMR Report
October 04, 2023 03:47 ET | Transparency Market Research
Wilmington, Delaware, United States, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The animal drug compounding market acquired US$ 1.1 billion in 2021. The market is likely...
Persistence Market Research
Animal Drug Compounding Market is set to witness healthy growth at a CAGR of 8% over the forecast period of 2021-2031
February 24, 2022 10:30 ET | Persistence Market Research
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Scarce availability of FDA-approved drug formulations for diseases in animals is mended through animal drug compounding, with varied formulations and...
Veterinary Drugs Market to reach US$ 27,570.0 Mn by 2025, at a CAGR of 5.6% | Exclusive Report by Fortune Business Insights
June 19, 2019 09:08 ET | Fortune Business Insights
Pune, June 19, 2019 (GLOBE NEWSWIRE) -- The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global Veterinary Drugs Market, finds Fortune Business...
PetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and Nutraceuticals
October 19, 2016 15:15 ET | PetLife Pharmaceuticals, Inc.
Hancock, MD, Oct. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Continues Execution of its Vitalzul TM Business Plan with start of Proof of Concept studies; Provides Updates
September 14, 2016 09:10 ET | PetLife Pharmaceuticals, Inc.
Hancock, MD, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Hancock, MD - PetLife Pharmaceuticals, Inc. (OTC QB: PTLFD) (the "Company"), a developer of Vitalzul™, a new generation of high potency veterinary...